We studied the growth fraction of55 resected colorectal adenocarcinomas by means of a three-step immunoperoxidase technique (avidin-biotin-peroxidase) using the monoclonal antibody Ki67 directed against a cell proliferation-associated nuclear antigen.
The percentage of Ki67-positive cells was evaluated independently by two observers, and a Ki67 score was obtained for each case.
No correlation was observed between Ki67 staining and patient's age and sex, tumor size and localization or grading and staging according to Dukes’ method (modified by Astler-Coller and Turnbull).
The growth fraction showed extreme heterogeneity in the cases examined, within each grade of differentiation.
LiebL.M., LiscoH.. In vitro uptake of tritiated thymidine by carcinoma of the human colon. Cancer Res1966; 26: 733–40.
2.
BleibergM., GalandP.. In vitro autoradiographic determination of cell kinetic parameters in adenocarcinomas and adjacent healthy mucosa of the human colon and rectum. Cancer Res1976; 36: 325–8.
3.
LesherS., SchifferL.M., PhanseM.. Human colonic tumour kinetics. Potential for therapy. Cancer1977; 40: 2706–9.
4.
MeyerJ.S., PrioleauP.G.. S-Phase fractions of colorectal carcinomas related to pathological and clinical features. Cancer1981; 48: 1221–8.
5.
QuirkeP., DixonM.F., ClaydenA.D.Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol1987; 151: 285–91.
6.
GerdesJ., LekerR.J., PichartzH.Growth fractions in breast cancer determined with monoclonal antibody Ki67. J Clin Path1986; 39: 977–80.
7.
BarnardN.J., HallP.A., LemoineN.R., KadarN.. Ki67 determined growth fraction in breast carcinoma: relation to clinical and pathologic variables. J Pathol1987; 152: 287–95.
8.
Mc GurrinJ.F., DoriaM.I., DawsonP.J., KarrisonT., SteinH.O., FranklinW.A.. Assessment of tumour cell kinetics by immunohistochemistry in carcinoma of the breast. Cancer1987; 59: 1744–50.
9.
BacusS.S., GoldschmidtT.R., ChinD., MoranG., WeinbergD., BacusJ.W.. Biological grading of breast cancer using antibodies to proliferating cell and other markers. Am J Pathol1989; 135: 783–92.
10.
KamelO.W., FranklinW.A., RingusJ.C., MeyerJ.S.. Thymidine labeling index and Ki67 growth fraction in lesions of the breast. Am J Pathol1989; 134: 107–13.
11.
GatterK.C., DunnilM.S., GerdesJ., SteinH., MasonD.Y.. New approach towards lung tumours in man. J Clin Pathol1986; 39: 590–3.
12.
FranklinW.A., Mc DonaldG., SteinH.Immunohistochemical demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol1985; 16: 1129–32.
13.
ShepherdN.A., RichmanP.I., EnglandJ.. Ki67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol1988; 155: 213–9.
14.
JohnstonP.G., O'BrienM.J., DerivanP.A., CarneyD.N.. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol1989; 20: 696–700.
15.
GerdesJ., DallenbachF., LennertH.Growth fractions in malignant non-Hodgkin's lymphoma (NHL) as determined in situ with the monoclonal antibody Ki67. Haematol Oncol1984; 2: 366–71.
16.
PileriS., GerdesJ., RivanoM.Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki67. Br J Haematol1987; 56: 271–6.
17.
HallP.A., RichardsM.A., GregoryW.M., D'ArdenneA.J., ListerT.A., StansfeldA.G.. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol1988; 154: 223–36.
18.
AstlerV.B., CollerF.A.. The prognostic significance of direct extension of carcinoma of the colon and the rectum. Ann Surg1954; 139: 846–51.
19.
TurnbullR.B.Jr., KyleK., WatsonF.R.. Cancer of the colon: the influence of the no touch isolation technique on survival rates. Ann Surg1967; 166: 420–7.
20.
HsuS.M., RaineL., FangerH.. The use of anti-avidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol1981; 75: 816–21.
21.
PorschenR., LoheB., HengelsK.J., BorchardF.. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki67. Correlation with pathohistologic criteria and influence of irradiation. Cancer1989; 64: 2501–5.
22.
ThomasG.D.H., DixonM.F., SmeetonN.C., WilliamsN.S.. Observer variation in the histological grading of rectal carcinoma. J Clin Pathol1983; 36: 385–91.
